跳到主要內容

臺灣博碩士論文加值系統

(44.222.64.76) 您好!臺灣時間:2024/06/17 09:22
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:許纘融
研究生(外文):HSU, TSUAN-JUNG ( alimoli Hsu)
論文名稱:藥廠對異位性皮膚炎用藥相關文案之科普化研究
論文名稱(外文):Studies on the Popularization of Drug-relatedDocuments for Atopic Dermatitis inPharmaceutical Factories
指導教授:黃世勳黃世勳引用關係
指導教授(外文):Shyh-Shyun Huang
學位類別:碩士
校院名稱:中國醫藥大學
系所名稱:製藥碩士學位學程
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:2020
畢業學年度:108
語文別:中文
論文頁數:174
中文關鍵詞:位性皮膚炎
外文關鍵詞:Atopic dermatitis
相關次數:
  • 被引用被引用:0
  • 點閱點閱:964
  • 評分評分:
  • 下載下載:55
  • 收藏至我的研究室書目清單書目收藏:0
藥廠對異位性皮膚炎用藥相關文案之科普化研究,異位性皮膚炎
(Atopic dermatitis,AD)是因為實習藥廠有製造異位性皮膚炎產品的專案,
為使相關文案用於日後在衛教與仿單外盒和包裝以及銷售能更專業而平
易簡明表達,也就是能夠兼具專業中又能淺顯易懂表達。
經由藥局實地訪查對於異位性皮膚炎疾病的認知,藥師是直接與
患者接觸最密集之一,經由藥局實地訪查了解藥師在異位性皮膚炎用藥,
所了解的病患,對異位性皮膚炎是如何看待。
也隨機訪查對疾病的瞭解,做隨機明瞭程度調查問卷,可以協助我
們在衛教和溝通與銷售時如何提供既專業又通俗,讓患者一目了然。
再配合大量PubMed 收集查閱醫藥學文獻,借助已知很棒但是深
奧難懂的醫藥學文獻,如何能科普出讓大眾看懂讀通呢?醫藥學文獻越寫
越細,越寫越專,很難看懂讀通,我們首次經由科普化後,可以做為藥廠
提升知識水平,亦可作為在溝通說明上有醫藥學的支撐點。
我們試圖突破困難讓醫藥學科普化,本論文所指的醫藥學科普是
必須依據嚴謹的醫藥學文獻,為加入適當的插畫圖案來增加和(或)輔助文
字說明,達到實用教育類、宣傳類、化繁為簡、串聯連結、縮減、增加的
效果、閱讀人群分為兒童、青少年、成人、老人、讓讀者能夠容易理解醫
學教育、知識、溝通、理念、用途等謂之醫藥學科普。
讓異位性皮膚炎患者和患者的照顧者,都能看得懂讀得通專業艱
深難懂的異位性皮膚炎醫藥學文獻,有幫助於患者的病情。異位性皮膚炎
的病因與發病機制迄今還是不完全清楚。
醫藥學科普既不同於科學論著,更不同於文學藝術,由於受到醫學
V
性、藥學性、科學性、思想性、通俗性、趣味性、時間線、地域性、宗教
性、人種、膚色等等的限制,要把醫藥學知識科普化,並非一件容易的事。
本研究藥廠對異位性皮膚炎用藥相關文案之科普化研究,經隨機
明瞭程度問卷調查後,達成高度瞭解程度,成果可以供Atopic dermatitis
病患及其照顧者都能看通讀懂醫藥學文獻科普,讓產品端的製藥業於外
包盒和裡面的仿單作為參考。
Studies on the Popularization of Drug-related Documents for Atopic
Dermatitis in Pharmaceutical Factories,Atopic dermatitis (AD) is because the
internship drug factory has a project to manufacture atopic dermatitis products,
It can be more professional and easy to express in health education,printing
of imitation sheets and outer box packaging and sales that is it can be both
professional and easy to understand.。
Through the pharmacy field visit to the understanding of the Atopic
dermatitis disease, the pharmacist is one of the most intensive contact with
the patient,Through the pharmacy field visit to understand the pharmacist''s
medication for Atopic dermatitis,the patients who understand the how to treat
Atopic dermatitis。
Random visits to understand the disease and do a randomized
questionnaire can help us how to provide professional and popular in health
education and communication and sales,so that patients can see at a glance。
In addition,with the massive collection and access to medical literature
on the website PubMed,with the help of well-known but esoteric medical
literature,how can science be popularized and let the general public understand
it? The more detailed the medical literature,the more specialized it is,It''s hard
to read and understand. After we have passed the popularization of science for
the first time,we can use it as a Pharmaceutical Factory to improve our
knowledge level and also as a supporting point for medical science in
communication and explanation。
VII
We try to break through the difficulties and make the medical discipline
universal,The definition of the general medical discipline referred to in my
thesis is:it is necessary to add and/or supplement text descriptions with
appropriate illustration patterns based on rigorous medical literature to achieve
practical education. Genres, publicity, simplification, concatenation,
reduction, increased effect, reading population is divided into children,
adolescents, adults, the elderly, so that readers can easily understand
medical education, knowledge, communication, ideas, uses, discipline.
etc。
It is helpful for patients with atopic dermatitis and their caregivers to read
and understand the medical literature of atopic dermatitis that is difficult to
understand through the profession. The etiology and pathogenesis of atopic
dermatitis are still not fully understood. 。
The medical science is different from scientific works, but also from
literature and art. Due to medical, pharmaceutical, scientific, ideological,
popular, interesting, timeline, regional, religious, ethnic, skin color,
etc. Restrictions, it is not easy to popularize medical knowledge. 。
The scientific research on the atopic dermatitis drug-related literature in
this research Pharmaceutical Factory has reached a high degree of
understanding after a randomized questionnaire survey, and the results can
be read and understood by Atopic dermatitis patients and their caregivers. 。
Literature popular science, let the pharmaceutical industry on the product side
in the outsourcing box and the copy inside as a reference。
誌謝 .................................................................................................................... I
中文摘要 ......................................................................................................... IV
Abstract ........................................................................................................... VI
英文簡稱-英文-中文對照表 .................................................................. X
圖目錄 ............................................................................................................. XI
第一章緒論 .................................................................................................. - 1 -
第一節研究緣起 .................................................................................... - 1 -
第二節研究目的 .................................................................................... - 1 -
第三節預期達成目標 ............................................................................ - 7 -
第二章文獻探討 ........................................................................................ - 10 -
第一節兒童異位性皮膚炎簡介 ......................................................... - 10 -
第二節異位性皮膚炎流行病學 ......................................................... - 11 -
第三節異位性皮膚炎的病理生理學 ................................................. - 14 -
第四節異位性皮膚炎臨床表徵現象 ................................................. - 17 -
第五節異位性皮膚炎診斷標準 ......................................................... - 20 -
第六節異位性皮膚炎皮損類型 ......................................................... - 23 -
第七節異位性皮膚炎的基礎治療 ..................................................... - 25 -
第八節異位性皮膚炎的治療 ............................................................. - 26 -
一、異位性皮膚炎經常反覆發作 ..................................................... - 26 -
二、正確的皮膚照顧 .......................................................................... - 27 -
三、癢與搔抓循環 .............................................................................. - 27 -
四、異位性皮膚炎的遺傳與誘發因子 ............................................. - 28 -
五、台灣皮膚病協會對異位性皮膚炎治療方案共識的概述 ......... - 32 -
IX
第三章研究內容與方法 ............................................................................ - 41 -
第一節研究內容 .................................................................................. - 41 -
第二節研究方法 .................................................................................. - 42 -
第四章結果 ................................................................................................ - 54 -
一、社區藥局訪查異位性皮膚炎認知 ............................................. - 54 -
二、設計異位性皮膚炎科普文案及隨機問卷 ................................. - 56 -
第五章討論 .............................................................................................. - 118 -
第六章結論 .............................................................................................. - 126 -
第七章參考文獻 ...................................................................................... - 127 -
附錄:................................................................................................... - 152 -
. Retrieved from
http://www.derma.org.tw/index.php?sort_no=1390546649&sort_s_n
o=1408934696&id=1408934955
. (2012). Retrieved from
http://www.air.org.tw/photo/%E5%8F%B0%E7%81%A3%E5%85%92%
E7%AB%A5%E7%95%B0%E4%BD%8D%E6%80%A7%E7%9A%AE%E8%8
6%9A%E7%82%8E%E8%A8%BA%E7%99%82%E5%8F%8A%E8%A1%9B
%E6%95%99%E6%8C%87%E5%BC%95%E6%89%8B%E5%86%8A(%E5%
96%AE%E9%9D%A2%E5%B0%8F%E6%AA%94)[1].pdf
Akdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C.,
Boguniewicz, M., Eigenmann, P., . . . Zuberbier, T. (2006a).
Diagnosis and treatment of atopic dermatitis in children and adults:
European Academy of Allergology and Clinical Immunology/American
Academy of Allergy, Asthma and Immunology/PRACTALL Consensus
Report. Allergy, 61(8), 969‐987. doi:10.1111/j.1398‐
9995.2006.01153.x
Akdis, C. A., Akdis, M., Bieber, T., Bindslev‐Jensen, C.,
Boguniewicz, M., Eigenmann, P., . . . Zuberbier, T. (2006b).
Diagnosis and treatment of atopic dermatitis in children and adults:
European Academy of Allergology and Clinical Immunology/American
Academy of Allergy, Asthma and Immunology/PRACTALL Consensus
Report. J Allergy Clin Immunol, 118(1), 152‐169.
doi:10.1016/j.jaci.2006.03.045
Alves Marcelino, J. L., Cardoso de Aguiar, R., Cabral Duarte, F.,
Célia Costa, A., & Pereira‐Barbosa, M. A. (2017). Pediatric
eosinophilic esophagitis in Portugal. Eur Ann Allergy Clin Immunol,
49(2), 66‐74.
Arikawa, J., Ishibashi, M., Kawashima, M., Takagi, Y.,
Ichikawa, Y., & Imokawa, G. (2002). Decreased levels of
sphingosine, a natural antimicrobial agent, may be associated
with vulnerability of the stratum corneum from patients with atopic
dermatitis to colonization by Staphylococcus aureus. J Invest
Dermatol, 119(2), 433‐439. doi:10.1046/j.1523‐
1747.2002.01846.x
- 128 -
Arnedo‐Pena, A., García‐Marcos, L., Carvajal Urueña, I.,
Busquets Monge, R., Morales Suárez‐Varela, M., Miner
Canflanca, I., . . . González Díaz, C. (2009). [Air pollution and
recent symptoms of asthma, allergic rhinitis, and atopic eczema in
schoolchildren aged between 6 and 7 years]. Arch Bronconeumol,
45(5), 224‐229. doi:10.1016/j.arbres.2008.10.004
Asher, M. I., Barry, D., Clayton, T., Crane, J., D''Souza,
W., Ellwood, P., . . . Stewart, A. W. (2001). The burden of
symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema
in children and adolescents in six New Zealand centres: ISAAC Phase
One. N Z Med J, 114(1128), 114‐120.
Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K.,
Strachan, D. P., Weiland, S. K., & Williams, H. (2006).
Worldwide time trends in the prevalence of symptoms of asthma,
allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases
One and Three repeat multicountry cross‐sectional surveys. Lancet,
368(9537), 733‐743. doi:10.1016/s0140‐6736(06)69283‐0
Avena‐Woods, C. (2017). Overview of atopic dermatitis. Am J Manag
Care, 23(8 Suppl), S115‐s123.
Böhme, M., Svensson, A., Kull, I., & Wahlgren, C. F. (2000).
Hanifin''s and Rajka''s minor criteria for atopic dermatitis: which do 2‐
year‐olds exhibit? J Am Acad Dermatol, 43(5 Pt 1), 785‐792.
doi:10.1067/mjd.2000.110070
Ballardini, N., Kull, I., Lind, T., Hallner, E., Almqvist,
C., Ostblom, E., . . . Wickman, M. (2012). Development and
comorbidity of eczema, asthma and rhinitis to age 12: data from the
BAMSE birth cohort. Allergy, 67(4), 537‐544. doi:10.1111/j.1398‐
9995.2012.02786.x
Barbarot, S., Bernier, C., Deleuran, M., De Raeve, L.,
Eichenfield, L., El Hachem, M., . . . Stalder, J. F. (2013).
Therapeutic patient education in children with atopic dermatitis:
position paper on objectives and recommendations. Pediatr
Dermatol, 30(2), 199‐206. doi:10.1111/pde.12045
Barnes, K. C. (2010). An update on the genetics of atopic dermatitis:
scratching the surface in 2009. J Allergy Clin Immunol, 125(1), 16‐
29.e11‐11; quiz 30‐11. doi:10.1016/j.jaci.2009.11.008
- 129 -
Berth‐Jones, J., Damstra, R. J., Golsch, S., Livden, J. K.,
Van Hooteghem, O., Allegra, F., & Parker, C. A. (2003).
Twice weekly fluticasone propionate added to emollient maintenance
treatment to reduce risk of relapse in atopic dermatitis: randomised,
double blind, parallel group study. Bmj, 326(7403), 1367.
doi:10.1136/bmj.326.7403.1367
Beyer, K., Nickel, R., Freidhoff, L., Björkstén, B., Huang,
S. K., Barnes, K. C., . . . Wahn, U. (2000). Association and
linkage of atopic dermatitis with chromosome 13q12‐14 and 5q31‐33
markers. J Invest Dermatol, 115(5), 906‐908. doi:10.1046/j.1523‐
1747.2000.00096.x
Blaiss, M. S., Steven, G. C., Bender, B., Bukstein, D. A.,
Meltzer, E. O., & Winders, T. (2019). Shared decision making for
the allergist. Ann Allergy Asthma Immunol, 122(5), 463‐470.
doi:10.1016/j.anai.2018.08.019
Blauvelt, A., de Bruin‐Weller, M., Gooderham, M., Cather, J.
C., Weisman, J., Pariser, D., . . . Shumel, B. (2017). Longterm
management of moderate‐to‐severe atopic dermatitis with
dupilumab and concomitant topical corticosteroids (LIBERTY AD
CHRONOS): a 1‐year, randomised, double‐blinded, placebocontrolled,
phase 3 trial. Lancet, 389(10086), 2287‐2303.
doi:10.1016/s0140‐6736(17)31191‐1
Bradley, M., Söderhäll, C., Luthman, H., Wahlgren, C. F.,
Kockum, I., & Nordenskjöld, M. (2002). Susceptibility loci for
atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a
Swedish population. Hum Mol Genet, 11(13), 1539‐1548.
doi:10.1093/hmg/11.13.1539
Breuer, K., Werfel, T., & Kapp, A. (2005). Safety and efficacy of
topical calcineurin inhibitors in the treatment of childhood atopic
dermatitis. Am J Clin Dermatol, 6(2), 65‐77.
doi:10.2165/00128071‐200506020‐00001
Brown, S. J., & Irvine, A. D. (2008). Atopic eczema and the filaggrin
story. Semin Cutan Med Surg, 27(2), 128‐137.
doi:10.1016/j.sder.2008.04.001
Brown, S. J., & McLean, W. H. (2009). Eczema genetics: current state
of knowledge and future goals. J Invest Dermatol, 129(3), 543‐
- 130 -
552. doi:10.1038/jid.2008.413
Brunner, P. M., Israel, A., Leonard, A., Pavel, A. B., Kim,
H. J., Zhang, N., . . . Guttman‐Yassky, E. (2019). Distinct
transcriptomic profiles of early‐onset atopic dermatitis in blood and
skin of pediatric patients. Ann Allergy Asthma Immunol, 122(3),
318‐330.e313. doi:10.1016/j.anai.2018.11.025
Brunner, P. M., Silverberg, J. I., Guttman‐Yassky, E., Paller,
A. S., Kabashima, K., Amagai, M., . . . Stingl, G. (2017).
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic
Disorder. J Invest Dermatol, 137(1), 18‐25.
doi:10.1016/j.jid.2016.08.022
Buraczewska, I., Berne, B., Lindberg, M., Törmä, H., &
Lodén, M. (2007). Changes in skin barrier function following longterm
treatment with moisturizers, a randomized controlled trial. Br J
Dermatol, 156(3), 492‐498. doi:10.1111/j.1365‐
2133.2006.07685.x
Burgess, J. A., Lowe, A. J., Matheson, M. C., Varigos, G.,
Abramson, M. J., & Dharmage, S. C. (2009). Does eczema lead
to asthma? J Asthma, 46(5), 429‐436.
doi:10.1080/02770900902846356
Burks, A. W., James, J. M., Hiegel, A., Wilson, G.,
Wheeler, J. G., Jones, S. M., & Zuerlein, N. (1998). Atopic
dermatitis and food hypersensitivity reactions. J Pediatr, 132(1),
132‐136. doi:10.1016/s0022‐3476(98)70498‐6
Calderón Rivera, J. S., Rosas Vargas, M. A., Mejía Rodríguez, S.
A., Moncada Alcón, A. M., Río del Navarro, B. E., & Sienra
Monge, J. J. (2007). [Uncommon manifestations of atopic
dermatitis]. Rev Alerg Mex, 54(3), 96‐103.
Capristo, C., Romei, I., & Boner, A. L. (2004). Environmental
prevention in atopic eczema dermatitis syndrome (AEDS) and asthma:
avoidance of indoor allergens. Allergy, 59 Suppl 78, 53‐60.
doi:10.1111/j.1398‐9995.2004.00652.x
Cartledge, N., & Chan, S. (2018). Atopic Dermatitis and Food Allergy:
A Paediatric Approach. Curr Pediatr Rev, 14(3), 171‐179.
doi:10.2174/1573396314666180613083616
Chang, W. C., Lee, C. H., Hirota, T., Wang, L. F., Doi,
- 131 -
S., Miyatake, A., . . . Tamari, M. (2012). ORAI1 genetic
polymorphisms associated with the susceptibility of atopic dermatitis
in Japanese and Taiwanese populations. PLoS One, 7(1), e29387.
doi:10.1371/journal.pone.0029387
Chiesa Fuxench, Z. C. (2017). Atopic Dermatitis: Disease Background and
Risk Factors. Adv Exp Med Biol, 1027, 11‐19. doi:10.1007/978‐3‐
319‐64804‐0_2
[The contribution of outdoor atmospheric pollution in respiratory pathology].
(1997). Rev Mal Respir, 14 Suppl 6, S1‐63.
Cookson, W. O. (2001). The genetics of atopic dermatitis: strategies,
candidate genes, and genome screens. J Am Acad Dermatol, 45(1
Suppl), S7‐9. doi:10.1067/mjd.2001.117026
Cookson, W. O., Ubhi, B., Lawrence, R., Abecasis, G. R.,
Walley, A. J., Cox, H. E., . . . Harper, J. I. (2001). Genetic
linkage of childhood atopic dermatitis to psoriasis susceptibility loci.
Nat Genet, 27(4), 372‐373. doi:10.1038/86867
Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J.,
Lane, M. E., Moustafa, M., . . . Ward, S. J. (2009).
Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol,
129(8), 1892‐1908. doi:10.1038/jid.2009.133
Cork, M. J., Robinson, D. A., Vasilopoulos, Y., Ferguson, A.,
Moustafa, M., MacGowan, A., . . . Tazi‐Ahnini, R. (2006).
New perspectives on epidermal barrier dysfunction in atopic
dermatitis: gene‐environment interactions. J Allergy Clin Immunol,
118(1), 3‐21; quiz 22‐23. doi:10.1016/j.jaci.2006.04.042
Cowell, R. A., Barense, M. D., & Sadil, P. S. (2019). A Roadmap for
Understanding Memory: Decomposing Cognitive Processes into
Operations and Representations. eNeuro, 6(4).
doi:10.1523/eneuro.0122‐19.2019
D''Auria, E., Banderali, G., Barberi, S., Gualandri, L.,
Pietra, B., Riva, E., & Cerri, A. (2016). Atopic dermatitis:
recent insight on pathogenesis and novel therapeutic target. Asian Pac
J Allergy Immunol, 34(2), 98‐108. doi:10.12932/ap0732.34.2.2016
Danby, S. G., & Cork, M. J. (2018). pH in Atopic Dermatitis. Curr Probl
Dermatol, 54, 95‐107. doi:10.1159/000489523
Darsow, U., Lübbe, J., Taïeb, A., Seidenari, S.,
- 132 -
Wollenberg, A., Calza, A. M., . . . Ring, J. (2005). Position
paper on diagnosis and treatment of atopic dermatitis. J Eur Acad
Dermatol Venereol, 19(3), 286‐295. doi:10.1111/j.1468‐
3083.2005.01249.x
David Boothe, W., Tarbox, J. A., & Tarbox, M. B. (2017). Atopic
Dermatitis: Pathophysiology. Adv Exp Med Biol, 1027, 21‐37.
doi:10.1007/978‐3‐319‐64804‐0_3
Dinakar, C., Fineman, S. M., & Tilles, S. A. (2018). Recent
advances in atopic dermatitis. Ann Allergy Asthma Immunol,
120(1), 8‐9. doi:10.1016/j.anai.2017.11.009
Drucker, A. M. (2017). Atopic dermatitis: Burden of illness, quality of
life, and associated complications. Allergy Asthma Proc, 38(1),
3‐8. doi:10.2500/aap.2017.38.4005
Dufresne, H., Bekel, L., Compain, S., Deladrière, E.,
Bellon, N., Bodemer, C., & Hadj‐Rabia, S. (2020). Efficiency
of a therapeutic patient education program in children with severe
atopic dermatitis. J Eur Acad Dermatol Venereol.
doi:10.1111/jdv.16513
Dynowska, D., Kolarzyk, E., Schlegel‐Zawadzka, M., &
Dynowski, W. (2002). [The contribution of food and airborne
allergens in the pathogenesis of atopic dermatitis]. Przegl Lek,
59(6), 453‐456.
Eichenfield, L. F., Ahluwalia, J., Waldman, A., Borok, J.,
Udkoff, J., & Boguniewicz, M. (2017). Current guidelines for the
evaluation and management of atopic dermatitis: A comparison of the
Joint Task Force Practice Parameter and American Academy of
Dermatology guidelines. J Allergy Clin Immunol, 139(4s), S49‐s57.
doi:10.1016/j.jaci.2017.01.009
Eichenfield, L. F., Ellis, C. N., Mancini, A. J., Paller, A. S., &
Simpson, E. L. (2012). Atopic dermatitis: epidemiology and
pathogenesis update. Semin Cutan Med Surg, 31(3 Suppl), S3‐5.
doi:10.1016/j.sder.2012.07.002
Eichenfield, L. F., Hanifin, J. M., Luger, T. A., Stevens, S. R.,
& Pride, H. B. (2003). Consensus conference on pediatric atopic
dermatitis. J Am Acad Dermatol, 49(6), 1088‐1095.
doi:10.1016/s0190‐9622(03)02539‐8
- 133 -
Eichenfield, L. F., Tom, W. L., Berger, T. G., Krol, A.,
Paller, A. S., Schwarzenberger, K., . . . Sidbury, R. (2014).
Guidelines of care for the management of atopic dermatitis: section 2.
Management and treatment of atopic dermatitis with topical
therapies. J Am Acad Dermatol, 71(1), 116‐132.
doi:10.1016/j.jaad.2014.03.023
Eichenfield, L. F., Tom, W. L., Chamlin, S. L., Feldman, S. R.,
Hanifin, J. M., Simpson, E. L., . . . Sidbury, R. (2014).
Guidelines of care for the management of atopic dermatitis: section 1.
Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol,
70(2), 338‐351. doi:10.1016/j.jaad.2013.10.010
Elmariah, S. B. (2017). Adjunctive Management of Itch in Atopic
Dermatitis. Dermatol Clin, 35(3), 373‐394.
doi:10.1016/j.det.2017.02.011
Erkkola, M., Kaila, M., Nwaru, B. I., Kronberg‐Kippilä, C.,
Ahonen, S., Nevalainen, J., . . . Virtanen, S. M. (2009).
Maternal vitamin D intake during pregnancy is inversely associated
with asthma and allergic rhinitis in 5‐year‐old children. Clin Exp
Allergy, 39(6), 875‐882. doi:10.1111/j.1365‐2222.2009.03234.x
Eshtiaghi, P., & Gooderham, M. J. (2018). Dupilumab: an evidencebased
review of its potential in the treatment of atopic dermatitis.
Core Evid, 13, 13‐20. doi:10.2147/ce.S133661
Ezzedine, K., & Kechichian, E. (2017). [Epidemiology of atopic
dermatitis]. Ann Dermatol Venereol, 144 Suppl 5, Vs4‐vs7.
doi:10.1016/s0151‐9638(18)30085‐1
Fernández‐Benítez, M. (2002). [Etiologic implication of foods in atopic
dermatitis: evidence in favor]. Allergol Immunopathol (Madr),
30(3), 114‐120. doi:10.1016/s0301‐0546(02)79103‐9
Ferreira, S., & Torres, T. (2018). Dupilumab for the Treatment of
Atopic Dermatitis. Actas Dermosifiliogr, 109(3), 230‐240.
doi:10.1016/j.ad.2017.10.012
Fleischer, D. M., Udkoff, J., Borok, J., Friedman, A.,
Nicol, N., Bienstock, J., . . . Eichenfield, L. F. (2017). Atopic
dermatitis: skin care and topical therapies. Semin Cutan Med Surg,
36(3), 104‐110. doi:10.12788/j.sder.2017.035
Fröschl, B., Arts, D., & Leopold, C. (2007). Corticosteroid therapy
- 134 -
in the treatment of pediatric patients with atopic dermatitis. GMS
Health Technol Assess, 3, Doc09.
Fuiano, N., & Incorvaia, C. (2012). Dissecting the causes of atopic
dermatitis in children: less foods, more mites. Allergol Int, 61(2),
231‐243. doi:10.2332/allergolint.11‐RA‐0371
Furue, M., Chiba, T., Tsuji, G., Ulzii, D., Kido‐Nakahara,
M., Nakahara, T., & Kadono, T. (2017). Atopic dermatitis:
immune deviation, barrier dysfunction, IgE autoreactivity and
new therapies. Allergol Int, 66(3), 398‐403.
doi:10.1016/j.alit.2016.12.002
Galaup, B. (1992). [Clinical diagnosis of atopic dermatitis]. Allerg Immunol
(Paris), 24(5), 164‐167.
Galli, E., Neri, I., Ricci, G., Baldo, E., Barone, M.,
Belloni Fortina, A., . . . Eichenfield, L. F. (2016). Consensus
Conference on Clinical Management of pediatric Atopic Dermatitis. Ital
J Pediatr, 42, 26. doi:10.1186/s13052‐016‐0229‐8
Ghosh, D., Bernstein, J. A., Khurana Hershey, G. K.,
Rothenberg, M. E., & Mersha, T. B. (2018). Leveraging
Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to
Precision Medicine. Front Immunol, 9, 2727.
doi:10.3389/fimmu.2018.02727
Giardina, E., Sinibaldi, C., Chini, L., Moschese, V.,
Marulli, G., Provini, A., . . . Novelli, G. (2006). Colocalization
of susceptibility loci for psoriasis (PSORS4) and atopic
dermatitis (ATOD2) on human chromosome 1q21. Hum Hered,
61(4), 229‐236. doi:10.1159/000095059
Gliński, W., Kruszewski, J., Silny, W., Kurzawa, R.,
Czarnecka‐Operacz, M., Baran, E., & Szepietowski, J.
(2004). [Diagnostic, prophylactic and therapeutic guidelines in
patients with atopic dermatitis. Position paper by the task force of the
National Specialists on Dermatology, Venereology and Allergology].
Pol Merkur Lekarski, 17 Suppl 3, 3‐15.
Gooderham, M. J., Hong, H. C., Eshtiaghi, P., & Papp, K. A.
(2018). Dupilumab: A review of its use in the treatment of atopic
dermatitis. J Am Acad Dermatol, 78(3 Suppl 1), S28‐s36.
doi:10.1016/j.jaad.2017.12.022
- 135 -
Gough, H., Grabenhenrich, L., Reich, A., Eckers, N.,
Nitsche, O., Schramm, D., . . . Keil, T. (2015). Allergic
multimorbidity of asthma, rhinitis and eczema over 20 years in the
German birth cohort MAS. Pediatr Allergy Immunol, 26(5), 431‐
437. doi:10.1111/pai.12410
Greer, F. R., Sicherer, S. H., & Burks, A. W. (2008). Effects of early
nutritional interventions on the development of atopic disease in
infants and children: the role of maternal dietary restriction,
breastfeeding, timing of introduction of complementary foods,
and hydrolyzed formulas. Pediatrics, 121(1), 183‐191.
doi:10.1542/peds.2007‐3022
Guo, Y., Li, P., Tang, J., Han, X., Zou, X., Xu,
G., . . . Yao, Z. (2016). Prevalence of Atopic Dermatitis in Chinese
Children aged 1‐7 ys. Sci Rep, 6, 29751. doi:10.1038/srep29751
Gupta, D. (2015). Atopic Dermatitis: A Common Pediatric Condition and Its
Evolution in Adulthood. Med Clin North Am, 99(6), 1269‐1285,
xii. doi:10.1016/j.mcna.2015.07.006
Gustafsson, D., Sjöberg, O., & Foucard, T. (2000). Development
of allergies and asthma in infants and young children with atopic
dermatitis‐‐a prospective follow‐up to 7 years of age. Allergy,
55(3), 240‐245. doi:10.1034/j.1398‐9995.2000.00391.x
Halbert, A. R., Weston, W. L., & Morelli, J. G. (1995). Atopic
dermatitis: is it an allergic disease? J Am Acad Dermatol, 33(6),
1008‐1018. doi:10.1016/0190‐9622(95)90295‐3
Halken, S. (2004). Prevention of allergic disease in childhood: clinical and
epidemiological aspects of primary and secondary allergy prevention.
Pediatr Allergy Immunol, 15 Suppl 16, 4‐5, 9‐32.
doi:10.1111/j.1399‐3038.2004.0148b.x
Hamid, Q., Boguniewicz, M., & Leung, D. Y. (1994). Differential in
situ cytokine gene expression in acute versus chronic atopic dermatitis.
J Clin Invest, 94(2), 870‐876. doi:10.1172/jci117408
He, H., & Guttman‐Yassky, E. (2019). JAK Inhibitors for Atopic
Dermatitis: An Update. Am J Clin Dermatol, 20(2), 181‐192.
doi:10.1007/s40257‐018‐0413‐2
Henderson, J., Northstone, K., Lee, S. P., Liao, H., Zhao,
Y., Pembrey, M., . . . Irvine, A. D. (2008). The burden of
- 136 -
disease associated with filaggrin mutations: a population‐based,
longitudinal birth cohort study. J Allergy Clin Immunol, 121(4),
872‐877.e879. doi:10.1016/j.jaci.2008.01.026
Hendricks, A. J., Manivannan, M., & Shi, V. Y. (2019). Clinical
Pearls on Sleep Management in Atopic Dermatitis. Dermatitis,
30(5), 287‐293. doi:10.1097/der.0000000000000523
Hirota, T., Takahashi, A., Kubo, M., Tsunoda, T., Tomita,
K., Sakashita, M., . . . Tamari, M. (2012). Genome‐wide
association study identifies eight new susceptibility loci for atopic
dermatitis in the Japanese population. Nat Genet, 44(11), 1222‐
1226. doi:10.1038/ng.2438
Hofer, M. F. (2000). [Atopic dermatitis: the first allergic step in children].
Rev Med Suisse Romande, 120(3), 263‐267.
Hoffjan, S., & Epplen, J. T. (2005). The genetics of atopic dermatitis:
recent findings and future options. J Mol Med (Berl), 83(9), 682‐
692. doi:10.1007/s00109‐005‐0672‐2
Holm, E. A., Wulf, H. C., Stegmann, H., & Jemec, G. B.
(2006). Life quality assessment among patients with atopic eczema. Br
J Dermatol, 154(4), 719‐725. doi:10.1111/j.1365‐
2133.2005.07050.x
Hon, K. L., Kung, J. S. C., Ng, W. G. G., & Leung, T. F. (2018).
Emollient treatment of atopic dermatitis: latest evidence and clinical
considerations. Drugs Context, 7, 212530.
doi:10.7573/dic.212530
Hwang, C. Y., Chen, Y. J., Lin, M. W., Chen, T. J., Chu, S.
Y., Chen, C. C., . . . Liu, H. N. (2010). Prevalence of atopic
dermatitis, allergic rhinitis and asthma in Taiwan: a national study
2000 to 2007. Acta Derm Venereol, 90(6), 589‐594.
doi:10.2340/00015555‐0963
Incorvaia, C., Frati, F., Verna, N., D''Alò, S., Motolese,
A., & Pucci, S. (2008). Allergy and the skin. Clin Exp Immunol,
153 Suppl 1(Suppl 1), 27‐29. doi:10.1111/j.1365‐2249.2008.03718.x
Irvine, A. D., & McLean, W. H. (2006). Breaking the (un)sound barrier:
filaggrin is a major gene for atopic dermatitis. J Invest Dermatol,
126(6), 1200‐1202. doi:10.1038/sj.jid.5700365
Islamaj Dogan, R., Murray, G. C., Névéol, A., & Lu, Z. (2009).
- 137 -
Understanding PubMed user search behavior through log analysis.
Database (Oxford), 2009, bap018. doi:10.1093/database/bap018
Ito, Y., Adachi, Y., Makino, T., Higashiyama, H.,
Fuchizawa, T., Shimizu, T., & Miyawaki, T. (2009).
Expansion of FOXP3‐positive CD4+CD25+ T cells associated with
disease activity in atopic dermatitis. Ann Allergy Asthma Immunol,
103(2), 160‐165. doi:10.1016/s1081‐1206(10)60170‐6
Jonas, S. (1988). Health promotion in medical education. Am J Health
Promot, 3(1), 37‐42, 51. doi:10.4278/0890‐1171‐3.1.37
Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H.,
Tada, Y., Saeki, H., . . . Tamaki, K. (2001). Thymus and
activation‐regulated chemokine in atopic dermatitis: Serum thymus
and activation‐regulated chemokine level is closely related with
disease activity. J Allergy Clin Immunol, 107(3), 535‐541.
doi:10.1067/mai.2001.113237
Kamińska, E. (2018). [The role of emollients in atopic dermatitis in
children]. Dev Period Med, 22(4), 396‐403.
Kanda, N., & Watanabe, S. (2012). Increased serum human β‐
defensin‐2 levels in atopic dermatitis: relationship to IL‐22 and
oncostatin M. Immunobiology, 217(4), 436‐445.
doi:10.1016/j.imbio.2011.10.010
Kapp, A. (1991). [Pathogenesis of atopic dermatitis]. Fortschr Med,
109(6), 145‐148.
Katayama, I., Aihara, M., Ohya, Y., Saeki, H., Shimojo,
N., Shoji, S., . . . Yamada, H. (2017). Japanese guidelines for
atopic dermatitis 2017. Allergol Int, 66(2), 230‐247.
doi:10.1016/j.alit.2016.12.003
Katayama, I., Kohno, Y., Akiyama, K., Ikezawa, Z.,
Kondo, N., Tamaki, K., & Kouro, O. (2011). Japanese
guideline for atopic dermatitis. Allergol Int, 60(2), 205‐220.
doi:10.2332/allergolint.11‐rai‐0333
Katoh, N. (2019). [CLINICAL PRACTICE GUIDELINES FOR THE
MANAGEMENT OF ATOPIC DERMATITIS: SOME POINTS IN THE
TREATMENT WITH TOPICAL CORTICOSTEROIDS]. Arerugi, 68(9),
1111‐1114. doi:10.15036/arerugi.68.1111
Katoh, N., Ohya, Y., Ikeda, M., Ebihara, T., Katayama,
- 138 -
I., Saeki, H., . . . Yamamoto‐Hanada, K. (2019). Clinical
practice guidelines for the management of atopic dermatitis 2018. J
Dermatol, 46(12), 1053‐1101. doi:10.1111/1346‐8138.15090
Katoh, N., Ohya, Y., Ikeda, M., Ebihara, T., Katayama,
I., Saeki, H., . . . Yamamoto‐Hanada, K. (2020). Japanese
guidelines for atopic dermatitis 2020. Allergol Int.
doi:10.1016/j.alit.2020.02.006
Kaufman, B. P., Guttman‐Yassky, E., & Alexis, A. F. (2018). Atopic
dermatitis in diverse racial and ethnic groups‐Variations in
epidemiology, genetics, clinical presentation and treatment. Exp
Dermatol, 27(4), 340‐357. doi:10.1111/exd.13514
Kawasaki, H., Kubo, A., Sasaki, T., & Amagai, M. (2011).
Loss‐of‐function mutations within the filaggrin gene and atopic
dermatitis. Curr Probl Dermatol, 41, 35‐46.
doi:10.1159/000323291
Kelsay, K. (2006). Management of sleep disturbance associated with atopic
dermatitis. J Allergy Clin Immunol, 118(1), 198‐201.
doi:10.1016/j.jaci.2006.04.038
Kharfi, M., Bel Hadjali, H., Khaled, A., Mokhtar, I., &
Kamoun, M. R. (2001). [Atopic dermatitis in Tunisia: epidemiological
and clinical aspects]. Ann Dermatol Venereol, 128(5), 623‐625.
Kim, J., Kim, B. E., & Leung, D. Y. M. (2019). Pathophysiology of
atopic dermatitis: Clinical implications. Allergy Asthma Proc, 40(2),
84‐92. doi:10.2500/aap.2019.40.4202
Kim, J. E., Kim, J. S., Cho, D. H., & Park, H. J. (2016).
Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic
Dermatitis. Int J Mol Sci, 17(8). doi:10.3390/ijms17081234
Kim, S. Y., Yang, S. W., Kim, H. L., Kim, S. H., Kim, S. J.,
Park, S. M., . . . Um, J. Y. (2013). Association between P478S
polymorphism of the filaggrin gene & atopic dermatitis. Indian J Med
Res, 138(6), 922‐927.
Kon, A. A., & Morrison, W. (2018). Shared Decision‐making in
Pediatric Practice: A Broad View. Pediatrics, 142(Suppl 3), S129‐
s132. doi:10.1542/peds.2018‐0516B
Koo, D., & Thacker, S. B. (2008). The education of physicians: a CDC
perspective. Acad Med, 83(4), 399‐407.
- 139 -
doi:10.1097/ACM.0b013e3181667e9a
Kraft, M., & Worm, M. (2017). Dupilumab in the treatment of
moderate‐to‐severe atopic dermatitis. Expert Rev Clin Immunol,
13(4), 301‐310. doi:10.1080/1744666x.2017.1292134
Krämer, U., Weidinger, S., Darsow, U., Möhrenschlager,
M., Ring, J., & Behrendt, H. (2005). Seasonality in symptom
severity influenced by temperature or grass pollen: results of a panel
study in children with eczema. J Invest Dermatol, 124(3), 514‐523.
doi:10.1111/j.0022‐202X.2005.23625.x
L??set, M., Brown, S. J., Saunes, M., & Hveem, K. (2019).
Genetics of Atopic Dermatitis: From DNA Sequence to Clinical
Relevance. Dermatology, 235(5), 355‐364.
doi:10.1159/000500402
Langan, S. M., & Williams, H. C. (2006). What causes worsening of
eczema? A systematic review. Br J Dermatol, 155(3), 504‐514.
doi:10.1111/j.1365‐2133.2006.07381.x
Laubereau, B., Brockow, I., Zirngibl, A., Koletzko, S.,
Gruebl, A., von Berg, A., . . . Wichmann, H. E. (2004). Effect
of breast‐feeding on the development of atopic dermatitis during the
first 3 years of life‐‐results from the GINI‐birth cohort study. J Pediatr,
144(5), 602‐607. doi:10.1016/j.jpeds.2003.12.029
LeBovidge, J., Borok, J., Udkoff, J., Yosipovitch, G., &
Eichenfield, L. F. (2017). Atopic dermatitis: therapeutic care delivery:
therapeutic education, shared decision‐making, and access to
care. Semin Cutan Med Surg, 36(3), 131‐136.
doi:10.12788/j.sder.2017.029
Lebwohl, M., & Herrmann, L. G. (2005). Impaired skin barrier function
in dermatologic disease and repair with moisturization. Cutis, 76(6
Suppl), 7‐12.
Lee, S. I., Kim, J., Han, Y., & Ahn, K. (2011). A proposal:
Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pac
Allergy, 1(2), 53‐63. doi:10.5415/apallergy.2011.1.2.53
Lee, Y. A., Wahn, U., Kehrt, R., Tarani, L., Businco, L.,
Gustafsson, D., . . . Reis, A. (2000). A major susceptibility locus
for atopic dermatitis maps to chromosome 3q21. Nat Genet,
26(4), 470‐473. doi:10.1038/82625
- 140 -
LePoidevin, L. M., Lee, D. E., & Shi, V. Y. (2019). A comparison of
international management guidelines for atopic dermatitis. Pediatr
Dermatol, 36(1), 36‐65. doi:10.1111/pde.13678
Leung, D. Y. (1997). Atopic dermatitis: immunobiology and treatment with
immune modulators. Clin Exp Immunol, 107 Suppl 1, 25‐30.
Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I.,
& Hamid, Q. A. (2004). New insights into atopic dermatitis. J Clin
Invest, 113(5), 651‐657. doi:10.1172/jci21060
Li, M., Cheng, R., Shi, M., Liu, J., Zhang, G., Liu,
Q., . . . Yao, Z. (2013). Analyses of FLG mutation frequency and
filaggrin expression in isolated ichthyosis vulgaris (IV) and atopic
dermatitis‐associated IV. Br J Dermatol, 168(6), 1335‐1338.
doi:10.1111/bjd.12206
Linde, Y. W. (1992). Dry skin in atopic dermatitis. Acta Derm Venereol Suppl
(Stockh), 177, 9‐13.
Lio, P. A., Lee, M., LeBovidge, J., Timmons, K. G., &
Schneider, L. (2014). Clinical management of atopic dermatitis:
practical highlights and updates from the atopic dermatitis practice
parameter 2012. J Allergy Clin Immunol Pract, 2(4), 361‐369; quiz
370. doi:10.1016/j.jaip.2014.02.015
Lipozencić, J., & Wolf, R. (2007). Atopic dermatitis: an update and
review of the literature. Dermatol Clin, 25(4), 605‐612, x.
doi:10.1016/j.det.2007.06.009
Lodén, M. (2003). Role of topical emollients and moisturizers in the
treatment of dry skin barrier disorders. Am J Clin Dermatol, 4(11),
771‐788. doi:10.2165/00128071‐200304110‐00005
Lodén, M. (2005). The clinical benefit of moisturizers. J Eur Acad Dermatol
Venereol, 19(6), 672‐688; quiz 686‐677. doi:10.1111/j.1468‐
3083.2005.01326.x
Lodén, M. (2012). Effect of moisturizers on epidermal barrier function. Clin
Dermatol, 30(3), 286‐296.
doi:10.1016/j.clindermatol.2011.08.015
Lorente, F., Romo, A., Laffond, E., & Dávila, I. (1998).
[Preventive measures for allergic diseases]. Allergol Immunopathol
(Madr), 26(3), 101‐113.
Lyons, J. J., Milner, J. D., & Stone, K. D. (2015). Atopic dermatitis
- 141 -
in children: clinical features, pathophysiology, and treatment.
Immunol Allergy Clin North Am, 35(1), 161‐183.
doi:10.1016/j.iac.2014.09.008
Maliyar, K., Sibbald, C., Pope, E., & Gary Sibbald, R. (2018).
Diagnosis and Management of Atopic Dermatitis: A Review. Adv Skin
Wound Care, 31(12), 538‐550.
doi:10.1097/01.ASW.0000547414.38888.8d
Manca, A., Cugusi, L., Dvir, Z., & Deriu, F. (2017). PubMed
should raise the bar for journal inclusion. Lancet, 390(10096),
734‐735. doi:10.1016/s0140‐6736(17)31943‐8
Manca, A., Moher, D., Cugusi, L., Dvir, Z., & Deriu, F.
(2018). How predatory journals leak into PubMed. Cmaj, 190(35),
E1042‐e1045. doi:10.1503/cmaj.180154
Mao, W., Mao, J., Zhang, J., Wang, L., Cao, D., &
Qu, Y. (2014). Atopic eczema: a disease modulated by gene and
environment. Front Biosci (Landmark Ed), 19, 707‐717.
doi:10.2741/4237
Marenholz, I., Nickel, R., Rüschendorf, F., Schulz, F.,
Esparza‐Gordillo, J., Kerscher, T., . . . Lee, Y. A. (2006).
Filaggrin loss‐of‐function mutations predispose to phenotypes
involved in the atopic march. J Allergy Clin Immunol, 118(4), 866‐
871. doi:10.1016/j.jaci.2006.07.026
Marín, A., Eseverri, J. L., & Botey, J. (1998). [From atopic
dermatitis to asthma]. Allergol Immunopathol (Madr), 26(3), 114‐
119.
McGrath, J. A. (2008). Filaggrin and the great epidermal barrier grief.
Australas J Dermatol, 49(2), 67‐73; quiz 73‐64.
doi:10.1111/j.1440‐0960.2008.00443.x
Micali, G., Paternò, V., Cannarella, R., Dinotta, F., &
Lacarrubba, F. (2018). Evidence‐based treatment of atopic
dermatitis with topical moisturizers. G Ital Dermatol Venereol,
153(3), 396‐402. doi:10.23736/s0392‐0488.18.05898‐4
Mihm, M. C., Jr., Soter, N. A., Dvorak, H. F., & Austen, K.
F. (1976). The structure of normal skin and the morphology of atopic
eczema. J Invest Dermatol, 67(3), 305‐312. doi:10.1111/1523‐
1747.ep12514346
- 142 -
Mohan, G. C., & Lio, P. A. (2015). Comparison of Dermatology and
Allergy Guidelines for Atopic Dermatitis Management. JAMA
Dermatol, 151(9), 1009‐1013.
doi:10.1001/jamadermatol.2015.0250
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016).
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch
Out? Clin Rev Allergy Immunol, 51(3), 263‐292.
doi:10.1007/s12016‐015‐8488‐5
Mortz, C. G., Andersen, K. E., Dellgren, C., Barington, T.,
& Bindslev‐Jensen, C. (2015). Atopic dermatitis from adolescence to
adulthood in the TOACS cohort: prevalence, persistence and
comorbidities. Allergy, 70(7), 836‐845. doi:10.1111/all.12619
Mounsey, S. J., & Agius, E. (2017). Atopic dermatitis. Br J Hosp Med
(Lond), 78(12), C183‐c187. doi:10.12968/hmed.2017.78.12.C183
Mu, Z., Zhao, Y., Liu, X., Chang, C., & Zhang, J. (2014).
Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol,
47(2), 193‐218. doi:10.1007/s12016‐014‐8415‐1
Munday, J., Bloomfield, R., Goldman, M., Robey, H.,
Kitowska, G. J., Gwiezdziski, Z., . . . Mikaszewska, M.
(2002). Chlorpheniramine is no more effective than placebo in
relieving the symptoms of childhood atopic dermatitis with a nocturnal
itching and scratching component. Dermatology, 205(1), 40‐45.
doi:10.1159/000063138
Nolan, K., & Marmur, E. (2012). Moisturizers: reality and the skin
benefits. Dermatol Ther, 25(3), 229‐233. doi:10.1111/j.1529‐
8019.2012.01504.x
Nomura, T., Kabashima, K., & Miyachi, Y. (2014). The panoply of
αβT cells in the skin. J Dermatol Sci, 76(1), 3‐9.
doi:10.1016/j.jdermsci.2014.07.010
Nutten, S. (2015). Atopic dermatitis: global epidemiology and risk factors.
Ann Nutr Metab, 66 Suppl 1, 8‐16. doi:10.1159/000370220
O''Connell, E. J. (2004). The burden of atopy and asthma in children.
Allergy, 59 Suppl 78, 7‐11. doi:10.1111/j.1398‐9995.2004.00563.x
O''Regan, G. M., & Irvine, A. D. (2008). The role of filaggrin loss‐offunction
mutations in atopic dermatitis. Curr Opin Allergy Clin
Immunol, 8(5), 406‐410. doi:10.1097/ACI.0b013e32830e6fb2
- 143 -
Obbagy, J. E., English, L. K., Wong, Y. P., Butte, N. F.,
Dewey, K. G., Fleischer, D. M., . . . Stoody, E. E. (2019).
Complementary feeding and food allergy, atopic
dermatitis/eczema, asthma, and allergic rhinitis: a systematic
review. Am J Clin Nutr, 109(Suppl_7), 890s‐934s.
doi:10.1093/ajcn/nqy220
OFFICE, U. S. G. P. Retrieved from
https://repository.library.georgetown.edu/bitstream/handle/10822/55
9354/making_health_care_decisions.pdf?sequence=1&isAllowed=y
Opel, D. J. (2018). A 4‐Step Framework for Shared Decision‐making in
Pediatrics. Pediatrics, 142(Suppl 3), S149‐s156.
doi:10.1542/peds.2018‐0516E
Ortiz‐Salvador, J. M., & Pérez‐Ferriols, A. (2017). Phototherapy in
Atopic Dermatitis. Adv Exp Med Biol, 996, 279‐286.
doi:10.1007/978‐3‐319‐56017‐5_23
Pénard‐Morand, C., Charpin, D., Raherison, C.,
Kopferschmitt, C., Caillaud, D., Lavaud, F., & Annesi‐
Maesano, I. (2005). Long‐term exposure to background air pollution
related to respiratory and allergic health in schoolchildren. Clin Exp
Allergy, 35(10), 1279‐1287. doi:10.1111/j.1365‐
2222.2005.02336.x
Paller, A. S. (1987). Allergy in atopic dermatitis. Prim Care, 14(3), 491‐
501.
Park, K. Y., Kim, D. H., Jeong, M. S., Li, K., & Seo, S. J.
(2010). Changes of antimicrobial peptides and transepidermal water
loss after topical application of tacrolimus and ceramide‐dominant
emollient in patients with atopic dermatitis. J Korean Med Sci,
25(5), 766‐771. doi:10.3346/jkms.2010.25.5.766
Patrizi, A., Raone, B., & Ravaioli, G. M. (2017). Safety and Efficacy
of Phototherapy in the Management of Eczema. Adv Exp Med Biol,
996, 319‐331. doi:10.1007/978‐3‐319‐56017‐5_27
Pavlis, J., & Yosipovitch, G. (2018). Management of Itch in Atopic
Dermatitis. Am J Clin Dermatol, 19(3), 319‐332.
doi:10.1007/s40257‐017‐0335‐4
Proksch, E., Fölster‐Holst, R., & Jensen, J. M. (2006). Skin barrier
function, epidermal proliferation and differentiation in eczema. J
- 144 -
Dermatol Sci, 43(3), 159‐169. doi:10.1016/j.jdermsci.2006.06.003
Purvis, D. J., Thompson, J. M., Clark, P. M., Robinson, E.,
Black, P. N., Wild, C. J., & Mitchell, E. A. (2005). Risk
factors for atopic dermatitis in New Zealand children at 3.5 years of
age. Br J Dermatol, 152(4), 742‐749. doi:10.1111/j.1365‐
2133.2005.06540.x
Rancière, F., Nikasinovic, L., Bousquet, J., & Momas, I.
(2013). Onset and persistence of respiratory/allergic symptoms in
preschoolers: new insights from the PARIS birth cohort. Allergy,
68(9), 1158‐1167. doi:10.1111/all.12208
Ricci, G., Dondi, A., & Patrizi, A. (2009). Useful tools for the
management of atopic dermatitis. Am J Clin Dermatol, 10(5), 287‐
300. doi:10.2165/11310760‐000000000‐00000
Ricci, G., Dondi, A., Patrizi, A., & Masi, M. (2009). Systemic
therapy of atopic dermatitis in children. Drugs, 69(3), 297‐306.
doi:10.2165/00003495‐200969030‐00005
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink‐
Wagner, A., Gelmetti, C., . . . Darsow, U. (2012).
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J
Eur Acad Dermatol Venereol, 26(8), 1045‐1060.
doi:10.1111/j.1468‐3083.2012.04635.x
Roduit, C., Frei, R., Depner, M., Karvonen, A. M., Renz,
H., Braun‐Fahrländer, C., . . . Doekes, G. (2017). Phenotypes
of Atopic Dermatitis Depending on the Timing of Onset and
Progression in Childhood. JAMA Pediatr, 171(7), 655‐662.
doi:10.1001/jamapediatrics.2017.0556
Roekevisch, E., Spuls, P. I., Kuester, D., Limpens, J., &
Schmitt, J. (2014). Efficacy and safety of systemic treatments for
moderate‐to‐severe atopic dermatitis: a systematic review. J Allergy
Clin Immunol, 133(2), 429‐438. doi:10.1016/j.jaci.2013.07.049
Romeo, S. P. (1995). Atopic dermatitis: the itch that rashes. Pediatr Nurs,
21(2), 157‐163.
Sacotte, R., & Silverberg, J. I. (2018). Epidemiology of adult atopic
dermatitis. Clin Dermatol, 36(5), 595‐605.
doi:10.1016/j.clindermatol.2018.05.007
Saeki, H. (2017). Management of Atopic Dermatitis in Japan. J Nippon Med
- 145 -
Sch, 84(1), 2‐11. doi:10.1272/jnms.84.2
Saeki, H., Furue, M., Furukawa, F., Hide, M., Ohtsuki,
M., Katayama, I., . . . Takehara, K. (2009). Guidelines for
management of atopic dermatitis. J Dermatol, 36(10), 563‐577.
doi:10.1111/j.1346‐8138.2009.00706.x
Saeki, H., Nakahara, T., Tanaka, A., Kabashima, K.,
Sugaya, M., Murota, H., . . . Katoh, N. (2016). Clinical
Practice Guidelines for the Management of Atopic Dermatitis 2016. J
Dermatol, 43(10), 1117‐1145. doi:10.1111/1346‐8138.13392
Sampson, H. A. (1983). Role of immediate food hypersensitivity in the
pathogenesis of atopic dermatitis. J Allergy Clin Immunol, 71(5),
473‐480. doi:10.1016/0091‐6749(83)90464‐5
Sampson, H. A. (1986). The role of "allergy" in atopic dermatitis. Clin Rev
Allergy, 4(1), 125‐138. doi:10.1007/bf02991191
Sampson, H. A., & McCaskill, C. C. (1985). Food hypersensitivity and
atopic dermatitis: evaluation of 113 patients. J Pediatr, 107(5),
669‐675. doi:10.1016/s0022‐3476(85)80390‐5
Sayama, K., Komatsuzawa, H., Yamasaki, K., Shirakata, Y.,
Hanakawa, Y., Ouhara, K., . . . Hashimoto, K. (2005). New
mechanisms of skin innate immunity: ASK1‐mediated keratinocyte
differentiation regulates the expression of beta‐defensins, LL37,
and TLR2. Eur J Immunol, 35(6), 1886‐1895.
doi:10.1002/eji.200425827
Sayaseng, K. Y., & Vernon, P. (2018). Pathophysiology and
Management of Mild to Moderate Pediatric Atopic Dermatitis. J
Pediatr Health Care, 32(2), S2‐s12.
doi:10.1016/j.pedhc.2017.10.002
Schäfer, T. (2005). [Prevention of atopic eczema. Evidence based
guidelines]. Hautarzt, 56(3), 232‐240. doi:10.1007/s00105‐004‐
0884‐3
Schäfer, T., Heinrich, J., Wjst, M., Adam, H., Ring, J.,
& Wichmann, H. E. (1999). Association between severity of atopic
eczema and degree of sensitization to aeroallergens in schoolchildren.
J Allergy Clin Immunol, 104(6), 1280‐1284. doi:10.1016/s0091‐
6749(99)70025‐4
Schram, M. E., Leeflang, M. M., JP, D. E. N. O., Spuls, P. I.,
- 146 -
& Bos, J. D. (2011). Validation and refinement of the Millennium
Criteria for atopic dermatitis. J Dermatol, 38(9), 850‐858.
doi:10.1111/j.1346‐8138.2011.01202.x
Scott, M., Flaherty, D., & Currall, J. (2011). Statistics: making
sense of what we see. J Small Anim Pract, 52(11), 560‐565.
doi:10.1111/j.1748‐5827.2011.01134.x
Seegräber, M., Srour, J., Walter, A., Knop, M., &
Wollenberg, A. (2018). Dupilumab for treatment of atopic
dermatitis. Expert Rev Clin Pharmacol, 11(5), 467‐474.
doi:10.1080/17512433.2018.1449642
Shah, R. A., Nwannunu, C. E., Limmer, A. L., Patel, R. R.,
Mui, U. N., & Tyring, S. K. (2019). Brief Update on Dermatologic
Uses of Methotrexate. Skin Therapy Lett, 24(6), 5‐8.
Shin, J. H., Chung, M. J., & Seo, J. G. (2016). A multistrain
probiotic formulation attenuates skin symptoms of atopic dermatitis in
a mouse model through the generation of CD4(+)Foxp3(+) T cells. Food
Nutr Res, 60, 32550. doi:10.3402/fnr.v60.32550
Sidbury, R., Davis, D. M., Cohen, D. E., Cordoro, K. M.,
Berger, T. G., Bergman, J. N., . . . Eichenfield, L. F. (2014).
Guidelines of care for the management of atopic dermatitis: section 3.
Management and treatment with phototherapy and systemic agents. J
Am Acad Dermatol, 71(2), 327‐349.
doi:10.1016/j.jaad.2014.03.030
Siegfried, E. C., Jaworski, J. C., Eichenfield, L. F., Paller, A.,
Hebert, A. A., Simpson, E. L., . . . Zane, L. (2018).
Developing drugs for treatment of atopic dermatitis in children (≥3
months to <18 years of age): Draft guidance for industry. Pediatr
Dermatol, 35(3), 303‐322. doi:10.1111/pde.13452
Silverberg, N. B. (2017). Typical and atypical clinical appearance of atopic
dermatitis. Clin Dermatol, 35(4), 354‐359.
doi:10.1016/j.clindermatol.2017.03.007
Silverberg, N. B., & Durán‐McKinster, C. (2017). Special
Considerations for Therapy of Pediatric Atopic Dermatitis. Dermatol
Clin, 35(3), 351‐363. doi:10.1016/j.det.2017.02.008
Simon, D., Wollenberg, A., Renz, H., & Simon, H. U. (2019).
Atopic Dermatitis: Collegium Internationale Allergologicum (CIA)
- 147 -
Update 2019. Int Arch Allergy Immunol, 178(3), 207‐218.
doi:10.1159/000497383
Simpson, E. L., Bieber, T., Guttman‐Yassky, E., Beck, L. A.,
Blauvelt, A., Cork, M. J., . . . Ardeleanu, M. (2016). Two
Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl
J Med, 375(24), 2335‐2348. doi:10.1056/NEJMoa1610020
Simpson, E. L., & Hanifin, J. M. (2006). Atopic dermatitis. Med Clin
North Am, 90(1), 149‐167, ix. doi:10.1016/j.mcna.2005.09.002
Sokolova, A., & Smith, S. D. (2015). Factors contributing to poor
treatment outcomes in childhood atopic dermatitis. Australas J
Dermatol, 56(4), 252‐257. doi:10.1111/ajd.12331
Spergel, J. M. (2010). From atopic dermatitis to asthma: the atopic march.
Ann Allergy Asthma Immunol, 105(2), 99‐106; quiz 107‐109,
117. doi:10.1016/j.anai.2009.10.002
Spergel, J. M., Mizoguchi, E., Brewer, J. P., Martin, T. R.,
Bhan, A. K., & Geha, R. S. (1998). Epicutaneous sensitization
with protein antigen induces localized allergic dermatitis and
hyperresponsiveness to methacholine after single exposure to
aerosolized antigen in mice. J Clin Invest, 101(8), 1614‐1622.
doi:10.1172/jci1647
Spergel, J. M., & Paller, A. S. (2003). Atopic dermatitis and the atopic
march. J Allergy Clin Immunol, 112(6 Suppl), S118‐127.
doi:10.1016/j.jaci.2003.09.033
Squire, L. R., & Wixted, J. T. (2011). The cognitive neuroscience of
human memory since H.M. Annu Rev Neurosci, 34, 259‐288.
doi:10.1146/annurev‐neuro‐061010‐113720
Stemmler, S., & Hoffjan, S. (2016). Trying to understand the genetics
of atopic dermatitis. Mol Cell Probes, 30(6), 374‐385.
doi:10.1016/j.mcp.2016.10.004
Strathie Page, S., Weston, S., & Loh, R. (2016). Atopic dermatitis
in children. Aust Fam Physician, 45(5), 293‐296.
Suárez‐Fariñas, M., Dhingra, N., Gittler, J., Shemer, A.,
Cardinale, I., de Guzman Strong, C., . . . Guttman‐Yassky, E.
(2013). Intrinsic atopic dermatitis shows similar TH2 and higher TH17
immune activation compared with extrinsic atopic dermatitis. J Allergy
Clin Immunol, 132(2), 361‐370. doi:10.1016/j.jaci.2013.04.046
- 148 -
Tan, A. U., & Gonzalez, M. E. (2012). Management of severe atopic
dermatitis in children. J Drugs Dermatol, 11(10), 1158‐1165.
Tappel, A. C., Cresce, N., & Zlotoff, B. (2018). What''s the story?
An analysis of children''s books about atopic dermatitis. Pediatr
Dermatol, 35(5), 607‐610. doi:10.1111/pde.13590
Tatsumi, H., Mitani, H., Haruki, Y., & Ogushi, Y. (2001).
Internet medical usage in Japan: current situation and issues. J Med
Internet Res, 3(1), E12. doi:10.2196/jmir.3.1.e12
Thygarajan, A., & Burks, A. W. (2008). American Academy of
Pediatrics recommendations on the effects of early nutritional
interventions on the development of atopic disease. Curr Opin
Pediatr, 20(6), 698‐702. doi:10.1097/MOP.0b013e3283154f88
Tokura, Y. (2010). Extrinsic and intrinsic types of atopic dermatitis. J
Dermatol Sci, 58(1), 1‐7. doi:10.1016/j.jdermsci.2010.02.008
Tollefson, M. M., & Bruckner, A. L. (2014). Atopic dermatitis: skindirected
management. Pediatrics, 134(6), e1735‐1744.
doi:10.1542/peds.2014‐2812
Vakharia, P. P., Chopra, R., & Silverberg, J. I. (2018). Systematic
Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized
Controlled Trials. Am J Clin Dermatol, 19(1), 15‐22.
doi:10.1007/s40257‐017‐0299‐4
Wüthrich, B. (1978). Serum IgE in atopic dermatitis: relationship to severity
of cutaneous involvement and course of disease as well as coexistence
of atopic respiratory diseases. Clin Allergy, 8(3), 241‐248.
Wahlgren, C. F. (1991). Itch and atopic dermatitis: clinical and experimental
studies. Acta Derm Venereol Suppl (Stockh), 165, 1‐53.
Wakao, F. (2018). [The Ideal Situation and Problem for Providing of Cancer
Information]. Gan To Kagaku Ryoho, 45(5), 769‐774.
Waldman, A. R., Ahluwalia, J., Udkoff, J., Borok, J. F., &
Eichenfield, L. F. (2018). Atopic Dermatitis. Pediatr Rev, 39(4),
180‐193. doi:10.1542/pir.2016‐0169
Wang, H. Y., Pizzichini, M. M., Becker, A. B., Duncan, J. M.,
Ferguson, A. C., Greene, J. M., . . . Sears, M. R. (2010).
Disparate geographic prevalences of asthma, allergic
rhinoconjunctivitis and atopic eczema among adolescents in five
Canadian cities. Pediatr Allergy Immunol, 21(5), 867‐877.
- 149 -
doi:10.1111/j.1399‐3038.2010.01064.x
Wang, I. J., Guo, Y. L., Lin, T. J., Chen, P. C., & Wu, Y. N.
(2010). GSTM1, GSTP1, prenatal smoke exposure, and atopic
dermatitis. Ann Allergy Asthma Immunol, 105(2), 124‐129.
doi:10.1016/j.anai.2010.04.017
Wang, I. J., Guo, Y. L., Weng, H. J., Hsieh, W. S., Chuang,
Y. L., Lin, S. J., & Chen, P. C. (2007). Environmental risk factors
for early infantile atopic dermatitis. Pediatr Allergy Immunol,
18(5), 441‐447. doi:10.1111/j.1399‐3038.2007.00550.x
Wang, I. J., & Lin, T. J. (2015). FLG P478S polymorphisms and
environmental risk factors for the atopic march in Taiwanese children:
a prospective cohort study. Ann Allergy Asthma Immunol, 114(1),
52‐57. doi:10.1016/j.anai.2014.10.019
Wang, I. J., Wang, J. Y., & Yeh, K. W. (2016). Childhood Atopic
Dermatitis in Taiwan. Pediatr Neonatol, 57(2), 89‐96.
doi:10.1016/j.pedneo.2015.08.005
Weidinger, S., Klopp, N., Rummler, L., Wagenpfeil, S.,
Novak, N., Baurecht, H. J., . . . Illig, T. (2005). Association of
NOD1 polymorphisms with atopic eczema and related phenotypes. J
Allergy Clin Immunol, 116(1), 177‐184.
doi:10.1016/j.jaci.2005.02.034
Weidinger, S., & Novak, N. (2016). Atopic dermatitis. Lancet,
387(10023), 1109‐1122. doi:10.1016/s0140‐6736(15)00149‐x
Weidinger, S., Rümmler, L., Klopp, N., Wagenpfeil, S.,
Baurecht, H. J., Fischer, G., . . . Illig, T. (2005). Association
study of mast cell chymase polymorphisms with atopy. Allergy,
60(10), 1256‐1261. doi:10.1111/j.1398‐9995.2005.00879.x
Werfel, T., Claes, C., Kulp, W., Greiner, W., & von der
Schulenburg, J. M. (2006). Therapy of atopic eczema. GMS Health
Technol Assess, 2, Doc19.
Williams, H., Stewart, A., von Mutius, E., Cookson, W., &
Anderson, H. R. (2008). Is eczema really on the increase worldwide?
J Allergy Clin Immunol, 121(4), 947‐954.e915.
doi:10.1016/j.jaci.2007.11.004
Williams, H. C. (1995). On the definition and epidemiology of atopic
dermatitis. Dermatol Clin, 13(3), 649‐657.
- 150 -
Williams, H. C. (2000). Epidemiology of atopic dermatitis. Clin Exp
Dermatol, 25(7), 522‐529. doi:10.1046/j.1365‐2230.2000.00698.x
Williams, H. C. (2005). Clinical practice. Atopic dermatitis. N Engl J Med,
352(22), 2314‐2324. doi:10.1056/NEJMcp042803
Winge, M. C., Hoppe, T., Berne, B., Vahlquist, A.,
Nordenskjöld, M., Bradley, M., & Törmä, H. (2011).
Filaggrin genotype determines functional and molecular alterations in
skin of patients with atopic dermatitis and ichthyosis vulgaris. PLoS
One, 6(12), e28254. doi:10.1371/journal.pone.0028254
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S.,
Deleuran, M., Fink‐Wagner, A., . . . Ring, J. (2018a).
Consensus‐based European guidelines for treatment of atopic eczema
(atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol
Venereol, 32(5), 657‐682. doi:10.1111/jdv.14891
Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S.,
Deleuran, M., Fink‐Wagner, A., . . . Ring, J. (2018b).
Consensus‐based European guidelines for treatment of atopic eczema
(atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol
Venereol, 32(6), 850‐878. doi:10.1111/jdv.14888
Wollenberg, A., Oranje, A., Deleuran, M., Simon, D.,
Szalai, Z., Kunz, B., . . . Darsow, U. (2016). ETFAD/EADV
Eczema task force 2015 position paper on diagnosis and treatment of
atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol
Venereol, 30(5), 729‐747. doi:10.1111/jdv.13599
Wu, W. F., Wan, K. S., Wang, S. J., Yang, W., & Liu, W. L.
(2011). Prevalence, severity, and time trends of allergic
conditions in 6‐to‐7‐year‐old schoolchildren in Taipei. J Investig Allergol
Clin Immunol, 21(7), 556‐562.
Xu, F., Yan, S., Li, F., Cai, M., Chai, W., Wu,
M., . . . Xu, J. (2012). Prevalence of childhood atopic dermatitis:
an urban and rural community‐based study in Shanghai, China. PLoS
One, 7(5), e36174. doi:10.1371/journal.pone.0036174
Yan, S., Chen, W., Zhang, Y., Li, J., & Chen, X. (2019).
Calcium release‐activated calcium modulator 1 as a therapeutic target
in allergic skin diseases. Life Sci, 228, 152‐157.
doi:10.1016/j.lfs.2019.05.001
- 151 -
Yang, S., Fujikado, N., Kolodin, D., Benoist, C., & Mathis,
D. (2015). Immune tolerance. Regulatory T cells generated early in life
play a distinct role in maintaining self‐tolerance. Science,
348(6234), 589‐594. doi:10.1126/science.aaa7017
台灣兒童過敏氣喘免疫及風濕病醫學會. (2012). Retrieved from
http://www.air.org.tw/photo/%E5%8F%B0%E7%81%A3%E5%85%92%
E7%AB%A5%E7%95%B0%E4%BD%8D%E6%80%A7%E7%9A%AE%E8%8
6%9A%E7%82%8E%E8%A8%BA%E7%99%82%E5%8F%8A%E8%A1%9B
%E6%95%99%E6%8C%87%E5%BC%95%E6%89%8B%E5%86%8A(%E5%
96%AE%E9%9D%A2%E5%B0%8F%E6%AA%94)[1].pdf
嘉基兒童醫學部. Retrieved from
http://www.cych.org.tw/pediatrics/education/%E7%95%B0%E4%BD%
8D%E6%80%A7%E7%9A%AE%E8%86%9A%E7%82%8E(Dr.%E7%8E%8B
%E5%A3%AF%E9%8A%98).pdf
臺灣皮膚科醫學會. Retrieved from
http://www.derma.org.tw/CKEdit/upload/files/2013%E7%95%B0%E4
%BD%8D%E6%80%A7%E7%9A%AE%E8%86%9A%E7%82%8E%E8%A1
%9B%E6%95%99.pdf
衛生福利部. Retrieved from
https://sdm.patientsafety.mohw.gov.tw/Public/Detail?sn=32&id=1035
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top